Novo Nordisk and AWS Team Up for AI Drug Discovery
Novo Nordisk is working with AWS to change how they find new medicines. They are using AI tools to identify targets and plan out new therapy designs. This move aims to make their research process much faster.
AWS is now the main cloud provider for the drug company. Both teams are also opening a new hub in London to build these technologies together. The goal is to solve complex biological problems using advanced computing.
This partnership shows how much big pharma is leaning into new tech. By automating parts of the lab work, they hope to bring life saving treatments to patients sooner. It is a major step forward for digital health research.
Comments (0)
No comments yet. Be the first!
More AI news
NewsGoogle AI Changes Its Search Advice After Bias Complaints
Google updated its search tool after it incorrectly told users to call emergency services based on a person's nationality.
NewsWhy AI Is Still Failing at Simple Tasks
Researchers gave an AI five thousand dollars to grow, but it could not even open a bank account.
NewsEnovis to Buy eCential Robotics
Enovis is expanding its surgical tech business by purchasing French company eCential Robotics.